Although, as we mentioned above, most of the data on MRGPRX2 comes from in vitro studies, there are also ongoing clinical trials using agonist of this receptor in chronic spontaneous urticaria and atopic dermatitis (12). The gene discussed is MRGPRX2; the disease is chronic idiopathic urticaria.